Researchers at Lawrence Livermore National Laboratory utilized an AI-driven platform to enhance antibody responses to evolving SARS-CoV-2 variants, focusing on machine learning methods to predict optimal antibody designs. This advancement could significantly impact vaccine effectiveness in affected countries globally amid ongoing pandemic-related challenges.

Read More:

• 🔗 medicalxpress.com